Catriona Yale, Chief Development Officer: Akero Therapeutics AKRO Sell · Filed 25/07/18

Trade details

Type: Insider sale
Amount: $71,756.74
Shares · price: 1,342 sh · $53.47 a share
Held after: 91,488 sh
Stock: Akero Therapeutics AKRO
Person: Catriona YaleChief Development Officer
Trade date: 25/07/16
Filed: 25/07/18
Days to filing: 2 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/16~25/08/15

Catriona Yale's recent trades

Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$28.4K
659 sh
$28.4K
Filed 25/09/12
Traded 25/09/11
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$457.7K
8,658 sh
$457.7K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$89.6K
1,633 sh
$89.6K
Filed 25/06/20
Traded 25/06/18
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$334K
6,210 sh
$334K
Filed 25/06/20
Traded 25/06/16
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$158.6K
2,895 sh
$158.6K
Filed 25/06/20
Traded 25/06/16

Catriona Yale, Chief Officer — sold $71.8K of Akero Therapeutics AKRO · 1.4% of holdings · 10b5-1 plan | Whalegun